Drug Cos. Fight Class Cert. For 'Opioid Babies' In MDL

Law360 (October 9, 2020, 9:29 PM EDT) -- Drugmakers and retailers facing multidistrict litigation over their alleged role in the opioid epidemic urged a federal judge Friday not to certify a class of legal guardians of babies born to mothers who took opioids during pregnancy, saying their personal injury claims can't be resolved collectively.

Allergan, Walmart and more than a dozen other companies told an Ohio federal judge that there are no common issues that unify the guardians who say their children were "bathed in opioids" as their bodies formed in utero. The babies were diagnosed with neonatal abstinence syndrome, in which infants whose mothers took opioids suffer from...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!